From Wikipedia, the free encyclopedia
Jump to: navigation, search
Perflubron structure.svg
Clinical data
ATC code
CAS Number
PubChem CID
ECHA InfoCard 100.006.391
Chemical and physical data
Formula C8BrF17
Molar mass 498.96 g/mol
3D model (JSmol)
Density 1.93 g/cm3
Melting point 6 °C (43 °F)
Boiling point 142 °C (288 °F)

Perflubron (INN/USAN, or perfluorooctyl bromide; brand name Imagent) is a contrast medium for magnetic resonance imaging, computer tomography and sonography.[1] It was approved for this use in the United States by the Food and Drug Administration in 1993.[2]

Experimental research[edit]

Perflubron has also been tested experimentally for use in liquid breathing in premature infants with respiratory distress.[3][4]

This molecular model of Perflubron is color-coded by electron density to illustrate the positive polarisation of the large bromine atom by the inductively electron-withdrawing perfluorooctyl chain.


  1. ^ Mattrey, R. F. (1989). "Perfluorooctylbromide: A new contrast agent for CT, sonography, and MR imaging". AJR. American journal of roentgenology. 152 (2): 247–252. PMID 2643258. doi:10.2214/ajr.152.2.247. 
  2. ^ FDA Approved Drug Products
  3. ^ Wolfson, M. R.; Kechner, N. E.; Roache, R. F.; Dechadarevian, J. P.; Friss, H. E.; Rubenstein, S. D.; Shaffer, T. H. (1998). "Perfluorochemical rescue after surfactant treatment: Effect of perflubron dose and ventilatory frequency". Journal of applied physiology (Bethesda, Md. : 1985). 84 (2): 624–640. PMID 9475875. 
  4. ^ Leach, C. L.; Greenspan, J. S.; Rubenstein, S. D.; Shaffer, T. H.; Wolfson, M. R.; Jackson, J. C.; Delemos, R.; Fuhrman, B. P. (1996). "Partial Liquid Ventilation with Perflubron in Premature Infants with Severe Respiratory Distress Syndrome". New England Journal of Medicine. 335 (11): 761–767. PMID 8778584. doi:10.1056/NEJM199609123351101.